A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells
Abstract HER3 is a member of the EGF receptor family and elevated expression is associated with cancer progression and therapy resistance. HER3-specific T-cell engagers might be a suitable treatment option to circumvent the limited efficacy observed for HER3-blocking antibodies in clinical trials. I...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/d989d218664f4b1999818ee6967f204d |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|